Furosemide is the diuretic of choice for the treatment of hypertension in chronic kidney disease but the adaptative changes in the distal nephron may decrease its efficacy. Hydrochlorothiazide is not believed to be efficient in this setting. In a randomized, double-blind, cross-over trial, 23 patients with hypertension and stage 4 or 5 chronic kidney disease received long-acting furosemide (60 mg) and hydrochlorothiazide (25 mg) for 3 months and then both diuretics for 3 months. Sodium and chloride fractional excretions were measured after 3 months of each diuretic and then after their association. A trend towards an increase in the fractional excretion of sodium and chloride was observed with furosemide and hydrochlorothiazide (P=not significant). The association of the two diuretics increased the fractional excretions of sodium and chloride from 3.4±1.8 to 4.9±2.8 and from 3.8±2.0 to 6.0±3.1, respectively (P<.05). Furosemide and hydrochlorothiazide decreased mean blood pressure by the same extent. The association of the two diuretics was more efficient on blood pressure. There were no differences between furosemide and hydrochlorothiazide with respect to natriuresis and blood pressure control in patients with hypertension and...Continue Reading
Associated Clinical Trials
Hypertension associated with early stage kidney disease. Complementary roles of circulating renin, the body sodium/volume state and duration of hypertension
Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion
Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function
Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure
The saluretic effect of the thiazide diuretic bemetizide in relation to the glomerular filtration rate
The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group
Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure
Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group
Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics
Effects of chlorothiazide on renal hemodynamics. Comparative study of acute administration in normotensive and hypertensive subjects
A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension
Thiazide and thiazide-like diuretics: an opportunity to reduce blood pressure in patients with advanced kidney disease
Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy
Role of sodium restriction and diuretic therapy for "resistant" hypertension in chronic kidney disease
Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure
Value of combined thiazide-loop diuretic therapy in chronic kidney disease: heart failure and renin-angiotensin-aldosterone blockade
Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease
Extracellular fluid volume expansion, arterial stiffness and uncontrolled hypertension in patients with chronic kidney disease
Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study
An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney
Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment
A Randomized Trial of Distal Diuretics versus Dietary Sodium Restriction for Hypertension in Chronic Kidney Disease.
Outcomes of diuretic use in pre-dialysis CKD patients with moderate renal deterioration attending tertiary care referral center
Analysis of Global Oxidative Status Using Multimarker Scores Reveals a Specific Association Between Renal Dysfunction and Diuretic Therapy in Older Adults.
How Do I Manage Hypertension in Patients with Advanced Chronic Kidney Disease Not on Dialysis? Perspectives from Clinical Practice.
Antihypertensive Agents: Mechanisms of Action
Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.